Daniel M. Sullivan, MD [clinicaltrials_resource:227783e4ac662b558b82e2dfbea73863]
CP-609,754 in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00006085]BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer [clinicaltrials:NCT00006086]Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors [clinicaltrials:NCT00006088]
overall official [clinicaltrials_vocabulary:overall-official]
Daniel M. Sullivan, MD [clinicaltrials_resource:227783e4ac662b558b82e2dfbea73863]
Bio2RDF identifier
227783e4ac662b558b82e2dfbea73863
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:227783e4ac662b558b82e2dfbea73863
affiliation [clinicaltrials_vocabulary:affiliation]
last name [clinicaltrials_vocabulary:last-name]
Daniel M. Sullivan, MD
role [clinicaltrials_vocabulary:role]
Study Chair
identifier
clinicaltrials_resource:227783e4ac662b558b82e2dfbea73863
title
Daniel M. Sullivan, MD
@en
type
label
Daniel M. Sullivan, MD [clinicaltrials_resource:227783e4ac662b558b82e2dfbea73863]
@en